Please login to the form below

Not currently logged in


This page shows the latest Darwin news and features for those working in and with pharma, biotech and healthcare.

Edging towards success

Edging towards success

Evolution tells us to look for small advantages, not big leaps

Latest news

  • Pfizer's basic instincts Pfizer's basic instincts

    It reminded me of one of the first ‘Darwin’s Medicine’ columns I wrote (‘ The Future of Pfizer(s)’).

  • Relics from the past Relics from the past

    Terms that were once perfectly descriptive now only serve to tell us how the world has changed

  • Chaperone Leadership Chaperone Leadership

    An insightful parallel between bosses and biology

  • The chief executive ostrich The chief executive ostrich

    Some of the most perplexing executive behaviour is simply Darwinian

  • Bayer's drop of the future Bayer's drop of the future

    Flipping through the pages of ‘Darwin’s Medicine’, I am reminded that I saw – and see – the challenge of business model design as one of capability acquisition. ... I’m just lucky to be standing on those of perhaps the greatest giant of all:

More from news
Approximately 32 fully matching, plus 62 partially matching documents found.

Latest Intelligence

  • Back to the future Back to the future

    It took me 120, 000 words to explain my findings in my 2017 book ‘Darwin’s Medicine’. ... Ultimately, this difference between firms and its consequence was, like much else, foreseen by Darwin himself.

  • Darwinian leadership in the life sciences industry Darwinian leadership in the life sciences industry

    It owes little to Buddha or to military training. It is about adaptation to the exceptional features of our industry environment and it owes much to Darwin.

  • For trials without tribulations, we must improve patient experience For trials without tribulations, we must improve patient experience

    Charles Darwin famously talked about survival of the fittest. The idea that those that have better adapted to their environment are more likely to succeed than those who don’t.

  • Pharma’s coral reef Pharma’s coral reef

    And since new capabilities take time to evolve, it is anything but surprising, when looked at through the lens of Darwin’s great idea, that these holobiont management capabilities are not ... in my book Darwin’s Medicine.

  • Building the Future Building the Future

    This series of articles is based on Professor Smith's new book Darwin's Medicine: How Life Science Business Models are Evolving.

More from intelligence
Approximately 3 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...